Pharming (PHAR) Tax Rate Growth (1y) (2021 - 2026)

Pharming (PHAR) Tax Rate Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,861.65 Bn 66,861.36 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn -
3 Akari Therapeutics 1,071.19 Bn 1,071.19 Bn -
4 BeOne Medicines 469.11 Bn 464.32 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.03 Bn 115.78 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.13 Bn 61.37 Bn 3.31 Bn
7 Belite Bio 63.44 Bn 63.44 Bn -
8 Argenx Se 55.97 Bn 50.78 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn
10 Pharming 8.96 Bn 8.91 Bn 65.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.40 Bn
Dec 31, 2025 -21.48 Bn
Sep 30, 2025 -4,094.00
Jun 30, 2025 -14.79 Bn
Mar 31, 2025 6.96 Bn
Dec 31, 2024 5,162.00
Sep 30, 2024 -475.00
Jun 30, 2024 252.00
Mar 31, 2024 -2.56 Bn
Dec 31, 2023 231.00
Sep 30, 2023 690.00
Jun 30, 2023 322.00
Mar 31, 2023 -412.00
Dec 31, 2022 -6,979.00
Sep 30, 2022 -1,110.00
Jun 30, 2022 -863.00
Mar 31, 2022 3,968.00
Dec 31, 2021 -16.92 Mn
Sep 30, 2021 734.00